Endogenous TLR4 agonists Mrp-8 &-14 mediate CNS injury in focal cerebral 
ischemia.

Gina, Gina; Prinz, Vincent; Albrecht, Marcus W.; Harhausen, Denise; Khojasteh, Uldus; Nacken, Wolfgang; Endrese, Matthias; Dirnagl, Ulrich; Nietfeld, Wilfried; Trendelenburg, George

doi:doi:10.1016/j.bbadis.2009.10.003

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Endogenous TLR4 agonists Mrp-8 &-14 mediate CNS injury in focal cerebral ischemia.

MPS-Authors

Gina, Gina
Max Planck Society;

Albrecht, Marcus W.
Max Planck Society;

/persons/resource/persons50445

Nietfeld, Wilfried
Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Gina, G., Prinz, V., Albrecht, M. W., Harhausen, D., Khojasteh, U., Nacken, W., et al. (2009). Endogenous TLR4 agonists Mrp-8 &-14 mediate CNS injury in focal cerebral ischemia. Mitochondrial Disease, 1198-1204. doi:doi:10.1016/j.bbadis.2009.10.003.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-7CEE-B

Abstract

Several reports have recently demonstrated a detrimental role of Toll-like receptors (TLR) in cerebral ischemia, while there is little information about the endogenous ligands which activate TLR-signaling. The myeloid related proteins-8 and-14 (Mrp8/S100A8; Mrp14/S100A9) have recently been characterized as endogenous TLR4-agonists, and thus may mediate TLR-activation in cerebral ischemia. Interestingly, not only TLR-mRNAs, but also Mrp8 and Mrp14 mRNA were found to be induced in mouse brain between 3 and 48 h after transient 1 h focal cerebral ischemia/reperfusion. Mrp-protein was expressed in the ischemic hemisphere, and co-labeled with CD11b-positive cells. To test the hypothesis that Mrp-signaling contributes to the postischemic brain damage, we subjected Mrp14-deficient mice, which also lack Mrp8 protein expression, to focal cerebral ischemia. Mrp14-deficient mice had significantly smaller lesion volumes when compared to wild-type littermates (130 ± 16 mm3 vs. 105 ± 28 mm3) at 2 days after transient focal cerebral ischemia (1 h), less brain swelling, and a reduced macrophage/microglia cell count in the ischemic hemisphere. We conclude that upregulation and signaling of Mrp-8 and-14 contribute to neuroinflammation and the progression of ischemic damage.